DCGI Chief Dr V G Somani tenure extended by 3 months

Published On 2022-08-17 11:30 GMT   |   Update On 2022-08-17 15:25 GMT
Advertisement

New Delhi: The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months, according to an order issued by the Union Health Ministry.

Dr Somani was appointed DCGI for a term of three years on August 14, 2019.
"It has been decided with the approval of the competent authority, that Dr VG Somani shall continue to hold the charge of the post Drugs Controller of India under FR 49(v) for a period of three months w.e.f 16.08.2022 or until further orders, whichever is earlier," the official letter by the Ministry stated.
Advertisement
The government had invited fresh applications for the position of the next DCGI in the month of February. The tenure of the current DCGI, VG Somani ended on August 15.
The DCGI heads the Central Drugs Standard Control Organization (CDSCO) which is responsible to ensure the quality of drug supply across the country. It also has the authority to give approval to new drugs and regulate clinical trials.


Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News